Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: AERINAZE
Active substances:
Estonian, English, Latin
ATC code: R01BA94
Dosage form: modified-release tablet
Strength: 120mg+2,5mg
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Indication: Aerinaze is indicated in adults and adolescents 12 years and older for the symptomatic treatment of seasonal allergic rhinitis when accompanied by nasal congestion.
Safety features: Yes
Marketing authorization holder: Organon N.V. 
Marketing authorization number: EU/1/07/399 
Marketing authorization issued on: July 30, 2007 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Assessment report:   
Description Additional condition
Hambaarstil on õigus välja kirjutada
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1327777  AERINAZE  modified-release tablet  120mg +2,5mg 2TK  Prescription           
1327788  AERINAZE  modified-release tablet  120mg +2,5mg 4TK  Prescription           
1327799  AERINAZE  modified-release tablet  120mg +2,5mg 7TK  Prescription           
1327801  AERINAZE  modified-release tablet  120mg +2,5mg 10TK  Prescription           
1327812  AERINAZE  modified-release tablet  120mg +2,5mg 14TK  Prescription           
1327823  AERINAZE  modified-release tablet  120mg +2,5mg 20TK  Prescription           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere